ANTIBODY-TO-IMAGING PIPELINE TO MONITOR DRUG-TARGET ENGAGEMENT IN BREAST TUMORS
Monoclonal antibody-based therapies have become standard treatments for both hematological and solid malignancies. Trastuzumab (TZM), a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2), is a key therapy for HER2+ breast cancer. However, therapeutic efficacy is often com...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | European Journal of Histochemistry |
| Subjects: | |
| Online Access: | https://www.ejh.it/ejh/article/view/4270 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!